C4 Therapeutics (CCCC) PT Raised to $13 at Stifel
Tweet
Share
E-mailGet Alerts CCCC Hot Sheet
Price: $3.71 --0%
Rating Summary:
10 Buy, 5 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 5 | Down: 4 | New: 18
Rating Summary:
10 Buy, 5 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 5 | Down: 4 | New: 18
Join SI Premium – FREE
Stifel analyst Bradley Canino raised the price target on C4 Therapeutics (NASDAQ: CCCC) to $13.00 (from $12.00) while maintaining a Buy rating.
You May Also Be Interested In
- Kepler Cheuvreux Upgrades Entain PLC (ENT:LN) (GMVHF) to Buy
- PEXA Group Ltd (PXA:AU) PT Lowered to AUD13.90 at Macquarie
- Air New Zealand Limited (AIR:NZ) (ANZFF) PT Lowered to NZD0.38 at Macquarie
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
